Evidence that PAR2-triggered prostaglandin E2 (PGE2) formation involves the ERK-cytosolic phospholipase A2-COX-1-microsomal PGE synthase-1 cascade in human lung epithelial cells

Cell Biochem Funct. 2008 Mar-Apr;26(2):279-82. doi: 10.1002/cbf.1434.

Abstract

We investigated possible involvement of three isozymes of prostaglandin E synthase (PGES), microsomal PGES-1 (mPGES-1), mPGES-2 and cytosolic PGES (cPGES) in COX-2-dependent prostaglandin E(2) (PGE(2)) formation following proteinase-activated receptor-2 (PAR2) stimulation in human lung epithelial cells. PAR2 stimulation up-regulated mPGES-1 as well as COX-2, but not mPGES-2 or cPGES, leading to PGE(2) formation. The PAR2-triggered up-regulation of mPGES-1 was suppressed by inhibitors of COX-1, cytosolic phospholipase A(2) (cPLA(2)) and MEK, but not COX-2. Finally, a selective inhibitor of mPGES-1 strongly suppressed the PAR2-evoked PGE(2) formation. PAR2 thus appears to trigger specific up-regulation of mPGES-1 that is dependent on prostanoids formed via the MEK/ERK/cPLA(2)/COX-1 pathway, being critical for PGE(2) formation.

MeSH terms

  • Arachidonic Acids / pharmacology
  • Butadienes / pharmacology
  • Cells, Cultured
  • Cyclooxygenase 1 / drug effects
  • Cyclooxygenase 1 / metabolism*
  • Dinoprostone / biosynthesis*
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology*
  • Epithelial Cells / metabolism
  • Extracellular Signal-Regulated MAP Kinases / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Gene Expression Profiling
  • Humans
  • Indoles / pharmacology
  • Intramolecular Oxidoreductases / drug effects
  • Intramolecular Oxidoreductases / genetics
  • Intramolecular Oxidoreductases / metabolism*
  • Isoenzymes / drug effects
  • Isoenzymes / metabolism
  • Lung / cytology
  • Nitriles / pharmacology
  • Nitrobenzenes / pharmacology
  • Phospholipases A2, Cytosolic / drug effects
  • Phospholipases A2, Cytosolic / metabolism*
  • Prostaglandin-E Synthases
  • Pyrazoles / pharmacology
  • RNA, Messenger / drug effects
  • RNA, Messenger / genetics
  • Receptor, PAR-2 / drug effects
  • Receptor, PAR-2 / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Sulfonamides / pharmacology
  • Up-Regulation / drug effects

Substances

  • Arachidonic Acids
  • Butadienes
  • Indoles
  • Isoenzymes
  • Nitriles
  • Nitrobenzenes
  • Pyrazoles
  • RNA, Messenger
  • Receptor, PAR-2
  • SC 560
  • Sulfonamides
  • U 0126
  • arachidonyltrifluoromethane
  • MK-886
  • N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
  • Cyclooxygenase 1
  • Extracellular Signal-Regulated MAP Kinases
  • Phospholipases A2, Cytosolic
  • Intramolecular Oxidoreductases
  • PTGES protein, human
  • PTGES2 protein, human
  • Prostaglandin-E Synthases
  • Dinoprostone